What is NovoCure's net change in cash?

NovoCure (NVCR) reported net change in cash of -$6.07M in Q1 2026.

How has NovoCure's net change in cash changed year-over-year?

NovoCure's net change in cash increased by 83.5% year-over-year, from -$36.66M to -$6.07M.

What is the long-term trend for NovoCure's net change in cash?

Over 4 years (2021 to 2025), NovoCure's net change in cash has grown at a 14.4% compound annual growth rate (CAGR), from -$36.56M to -$62.7M.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

NovoCure NVCR Net Change in Cash

Net Change in Cash at other companies

Boston ScientificBSX

-$504M-261%

MedtronicMDT

-$136M+11.7%

Iovance Biotherapeutics, Inc.IOVA

$33.44M-40.3%

Nuvation BioNUVB

-$38.7M-416%

Vir Biotechnology, Inc.VIR

$41.97M-14.9%

Syndax PharmaceuticalsSNDX

-$4.04M-4,386%

Other financials

Income statement

See full

Revenue$174.1M+12.3%

Gross profit$135.1M+16.0%

Operating income-$67.4M-78.1%

Net income-$71.1M-107%

EPS (diluted)-$0.62-100%

Balance sheet

See full

Cash & equivalents$87.5M-31.2%

Total debt$39.5M-2.1%

Total equity$330.7M-8.6%

Total assets$787.9M-36.9%

Cash flow

See full

Operating cash flow-$13.5M+62.1%

CapEx$5.2M-51.4%

Free cash flow-$18.7M+59.7%

Valuation

See full

Market cap$1.7B-36.7%

Enterprise value$1.66B-36.3%

P/S2.5×-1.8×

Profitability

See full

Gross margin75.2%-2.0pp

Operating margin-27.2%+0.4pp

Net margin-25.7%-0.7pp

FCF margin-7.1%-2.0pp

Returns & leverage

See full

Return on equity-50%+5.4pp

Debt / equity0.1×0.0×

Current ratio2.9×+1.4×

Where this comes from

Reported directly by NovoCure in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: NovoCure’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about NovoCure's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is NovoCure's net change in cash?: NovoCure (NVCR) reported net change in cash of -$6.07M in Q1 2026.
How has NovoCure's net change in cash changed year-over-year?: NovoCure's net change in cash increased by 83.5% year-over-year, from -$36.66M to -$6.07M.
What is the long-term trend for NovoCure's net change in cash?: Over 4 years (2021 to 2025), NovoCure's net change in cash has grown at a 14.4% compound annual growth rate (CAGR), from -$36.56M to -$62.7M.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.